COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
The distinction between cyclooxygenase-2-selective inhibitors (CSIs) and nonsteroidal anti-inflammatory drugs ultimately must be clinical and must be clinically and economically relevant. This distinction needs to be demonstrated in a substantial and clinically relevant difference in the respective...
Na minha lista:
| Publicado no: | Arthritis Res Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC165043/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12723976/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar747 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|